10.03
price up icon33.73%   2.53
after-market After Hours: 10.04 0.010 +0.10%
loading

Aditxt Inc Stock (ADTX) Latest News

pulisher
Mar 19, 2025

Aditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025 - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Top Small Cap Stocks To ResearchMarch 18th - MarketBeat

Mar 19, 2025
pulisher
Mar 18, 2025

Aditxt Shares Up After Acquisition Target Appili Files Funding Plans -March 18, 2025 at 02:47 pm EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

S&P 500 Down 1%; Sarepta Therapeutics Shares Plunge - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

Why Aditxt (ADTX) Stock Is Skyrocketing - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

Aditxt more than doubles after Appili takeover deadline extended - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

Dow Dips Over 200 Points; US Industrial Production Increases More than Expected - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

Appili Therapeutics expects Aditxt transaction to close in Q1 - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update - Lelezard

Mar 18, 2025
pulisher
Mar 18, 2025

Appili Therapeutics Announces Submission Of US Federal Government Funding Proposals And Provides Corporate And Aditxt Transaction Update - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate - EIN News

Mar 18, 2025
pulisher
Mar 18, 2025

Aditxt advances on drug trials and acquisition strategies By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 17, 2025

Dow Jumps 400 Points; US Retail Sales Increase Less Than Expected - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

Aditxt Provides Business Status Overview and Announces Launch of Aditxt Weekly Update Starting Friday, March 21, 2025 - Quantisnow

Mar 17, 2025
pulisher
Mar 17, 2025

Upcoming Stock Splits This Week (March 17 to March 21) – Stay Invested - The Globe and Mail

Mar 17, 2025
pulisher
Mar 14, 2025

Aditxt shares fall on 1-for-250 reverse stock split - MSN

Mar 14, 2025
pulisher
Mar 13, 2025

ADTX stock plunges to 52-week low, touches $0.04 - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Crude Oil Falls 1%; Dollar General Posts Upbeat Sales - Benzinga

Mar 13, 2025
pulisher
Mar 13, 2025

Nasdaq Down Over 100 Points; US Producer Inflation Stalls In February - Benzinga

Mar 13, 2025
pulisher
Mar 13, 2025

ADTX stock plunges to 52-week low, touches $0.04 By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

US Stocks Likely To Open Lower After A Brief Respite: 'Add Exposure To Equities' Amid Pullback, Says Expert - Benzinga

Mar 13, 2025
pulisher
Mar 13, 2025

Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 13, 2025
pulisher
Mar 12, 2025

Aditxt announces 1-for-250 reverse stock split By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Aditxt announces 1-for-250 reverse stock split effective March 17 - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Aditxt announces 1-for-250 reverse stock split - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Mar 12, 2025
pulisher
Mar 12, 2025

Aditxt, Inc. Announces Reverse Stock Split Plan - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025 - Business Wire

Mar 12, 2025
pulisher
Mar 10, 2025

Bulls Turn to Pennies STSS, ADTX, CSDX, SPRC, CBDW, YGTFF During Market Uncertainty – Small-Cap Stocks Poised for Big Moves - Financial Content

Mar 10, 2025
pulisher
Mar 07, 2025

Aditxt advances autoimmune therapy ADI-100 toward trials - Investing.com Australia

Mar 07, 2025
pulisher
Mar 06, 2025

Aditxt advances autoimmune therapy ADI-100 toward trials By Investing.com - Investing.com Canada

Mar 06, 2025
pulisher
Mar 06, 2025

Aditxt’s Adimune to ship substances for product formulation of of ADI-100 - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome at the Mayo Clinic in the U.S. - Quantisnow

Mar 06, 2025
pulisher
Mar 04, 2025

Aditxt approves reverse stock split, adjourns special meeting By Investing.com - Investing.com Australia

Mar 04, 2025
pulisher
Mar 03, 2025

Aditxt approves reverse stock split, adjourns special meeting - Investing.com India

Mar 03, 2025
pulisher
Mar 01, 2025

Short Interest in Aditxt, Inc. (NASDAQ:ADTX) Expands By 638.6% - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Stocks Under $1: PMAX PRSO ARBB KAVL to Watch in March 2025 – More Stocks Inside - Financial Content

Feb 28, 2025
pulisher
Feb 28, 2025

Aditx Therapeutics stock hits 52-week low at $0.07 By Investing.com - Investing.com Australia

Feb 28, 2025
pulisher
Feb 27, 2025

Aditx Therapeutics stock hits 52-week low at $0.07 - Investing.com India

Feb 27, 2025
pulisher
Feb 27, 2025

Is the Market Bullish or Bearish on Aditxt? - Benzinga

Feb 27, 2025
pulisher
Feb 26, 2025

Such Is The Power Of Aditxt Inc (NASDAQ: ADTX) - Stocks Register

Feb 26, 2025
pulisher
Feb 26, 2025

Aditxt Unveils Strategic Initiatives During Virtual Fireside Chat - Defense World

Feb 26, 2025
pulisher
Feb 26, 2025

Financial Health Check: Examining Aditxt Inc (ADTX)’s Key Ratios - The Dwinnex

Feb 26, 2025
pulisher
Feb 25, 2025

Aditxt, Inc. Discusses Pearsanta’s Planned IPO and Innovations - TipRanks

Feb 25, 2025
pulisher
Feb 25, 2025

Top 5 Biotech Stocks That Saw Biggest Retail Following Jump Last Week - Asianet Newsable

Feb 25, 2025
pulisher
Feb 24, 2025

Microcap Biotech Aditxt Rallies Retail Interest Ahead Of CEO’s Fireside Chat: What’s On Investors’ Radar? - Asianet Newsable

Feb 24, 2025
$78.94
price up icon 2.53%
$318.85
price up icon 1.51%
$33.41
price up icon 0.00%
$20.11
price up icon 1.41%
$99.27
price up icon 0.31%
biotechnology ONC
$266.26
price up icon 1.87%
Cap:     |  Volume (24h):